Table 1. Urine and serum analyses and body weight.
Controls w4 | Cisplatin 4w | Controls 9w | Cisplatin 9w | |
Body weight (g) | 375 ± 37 | 305 ± 17 a | 406 ± 26 | 358 ± 37 b |
Serum Creatinine (mg/dl) | 0.30 ± 0.07 | 0.42 ± 0.04 a | 0.27 ± 0.03 | 0.54 ± 0.13 b |
Serum Mg2+ (mg/dl) | 2.60 ± 0.40 | 2.71 ± 0.24 | 2.55 ± 0.34 | 2.90 ± 0.32 |
Serum Na+ (meq/l) | 143.13 ± 3.21 | 147.37 ± 5.57 | 146.00 ± 6.47 | 146.50 ± 4.35 |
Serum K+ (meq/l) | 5.66 ± 1.80 | 5.51 ± 0.61 | 5.51 ± 0.33 | 5.27 ± 0.90 |
FE Mg2+ (%) | 9.23 ± 4.52 | 32.56 ± 21.50 a,b | 9.06 ± 3.08 | 20.15 ± 8.60 |
FE Na+ (%) | 0.19 ± 0.11 | 0.18 ± 0.15 | 0.11 ± 0.06 | 0.24 ± 0.20 |
Data are presented in 4 groups: control animals receiving vehicle only, cisplatin-treated animals (2.5 mg/kg/w during 3 weeks) at 4 and 9 weeks after treatment with vehicle or cisplatin. Data are presented as means ± SD. Statistics were performed using generalized linear models. ap<0.05 versus controls at 4 weeks, bp<0.05 versus controls at 9 weeks.